Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.
Saved in:
| Title: | Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls. |
|---|---|
| Authors: | Muir RT; Calgary Stroke Program, University of Calgary, Calgary, Alberta, Canada.; Hotchkiss Brain Institute, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Community Health Sciences, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.; L.C Campbell Cognitive Neurology Research Unit, Dr Sandra Black Centre for Brain Resilience and Recovery, and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, North York, Ontario, Canada., Stukas S; Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada., Cooper JG; Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada., Beaudin AE; Hotchkiss Brain Institute, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada., McCreary CR; Hotchkiss Brain Institute, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.; Departments of Radiology, University of Calgary, Calgary, Alberta, Canada., Gee M; Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Nelles K; Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Nukala N; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada., Valencia J; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada., Kirmess KM; C2N Diagnostics, St. Louis, Missouri, USA., Black SE; L.C Campbell Cognitive Neurology Research Unit, Dr Sandra Black Centre for Brain Resilience and Recovery, and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, North York, Ontario, Canada., Hill MD; Calgary Stroke Program, University of Calgary, Calgary, Alberta, Canada.; Hotchkiss Brain Institute, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Community Health Sciences, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada., Camicioli R; Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada., Wellington CL; Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada., Smith EE; Calgary Stroke Program, University of Calgary, Calgary, Alberta, Canada.; Hotchkiss Brain Institute, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Community Health Sciences, Departments of Radiology, University of Calgary, Calgary, Alberta, Canada.; Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2025 Mar; Vol. 21 (3), pp. e70010. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.70010 |
